Related Experiment Video
Updated: May 8, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Melperone in treatment-refractory schizophrenia: a case series
Eromona Whiskey1, Marta Vavrova, Fiona Gaughran
1National Psychosis Service, South London and Maudsley NHS Foundation Trust, London, UK.
Objective:
Clozapine is the treatment of choice in refractory schizophrenia, but a substantial proportion of patients experience inadequate response or tolerate the drug poorly. Melperone has been suggested as a possible alternative in such patients. This case series examines the efficacy of melperone in refractory schizophrenia.
Method:
All patients prescribed melperone at the South London and Maudsley NHS Foundation Trust were identified using a pharmacy database. The main outcome was to determine the proportion of patients discharged on melperone.
Results:
Three of 21 patients were discharged on melperone. The primary reason for discontinuation was lack of efficacy.
Conclusion:
Melperone may be an option in a very few patients with refractory schizophrenia, but it should not be considered as an alternative to clozapine.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: MAOIs and Other Agents
Psychosis and Antipsychotic Drugs: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...